Type 2 Diabetes

For decades, body mass index (BMI) has been the standard tool for assessing metabolic health and diabetes risk. However, many clinicians now question whether weight alone tells the full story. Some people with a “normal” BMI still develop insulin resistance and type 2 diabetes, while others with higher body weight …

As diabetes rates continue to rise across the United States, another healthcare challenge is becoming harder to ignore: the diabetes workforce shortage. While new medications, continuous glucose monitors, and AI-supported tools are changing care, many patients still struggle to find specialists who can help them manage complex treatment plans. This …

Diabetes-related complications often bring to mind kidney disease, neuropathy, or vision problems. However, one complication continues to receive far less attention despite growing scientific concern: hearing loss linked to diabetes. Emerging evidence suggests that people with diabetes may face a significantly higher risk of hearing decline, yet routine auditory screening …

For many people living with diabetes, foot complications often begin quietly. A small pressure point, unnoticed inflammation, or minor skin breakdown can slowly develop into a serious ulcer. Unfortunately, traditional diabetic foot care has long been reactive. Clinicians typically intervene after visible wounds appear, when treatment becomes more difficult and …

A bowl of oatmeal can keep one person’s glucose stable while sending another person’s blood sugar sharply upward. The meal is identical, yet the metabolic response is completely different. That reality is pushing many clinicians to reconsider one of the most established principles in diabetes nutrition: carb counting. The growing …

Automated insulin delivery for people with type 2 diabetes is entering a new phase. What once seemed reserved for highly specialized endocrinology clinics is now moving steadily into primary care offices across the country. Following the updated 2026 American Diabetes Association Standards of Care and recent FDA clearances, more adults …

A glucose alarm goes off during dinner. Another alert appears at 2 a.m. A smartphone app flashes warnings about rising blood sugar before the day even starts. Diabetes technology promises better control, yet for some patients, the nonstop stream of notifications and health data can feel mentally exhausting. Clinicians are …

Screening for fatty liver disease in patients with diabetes is no longer limited to identifying elevated liver enzymes or calculating a fibrosis score during an annual visit. Instead, clinicians are entering an era where diabetes care and hepatology increasingly overlap, especially as metabolic dysfunction-associated steatotic liver disease, or MASLD, becomes …

Young adults diagnosed with type 2 diabetes early in life often face a more aggressive disease course than older adults. While metformin has long served as the standard first-line therapy, many clinicians are now reconsidering whether a “metformin-first and wait” strategy is enough for this higher-risk population. As research continues …

Diabetic retinopathy remains one of the leading causes of preventable blindness worldwide. Yet despite clear screening guidelines, many patients with diabetes still miss their annual retinal exams. Busy schedules, limited specialist access, transportation barriers, and lack of awareness often delay diagnosis until vision changes become permanent. As healthcare systems search …